Nov 2 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 333 mln 350 mln 773 mln
(-4.8 pct) (+29.2 pct) (+4.2 pct)
Operating loss 39 mln loss 97 mln loss 116 mln
Recurring loss 37 mln loss 108 mln loss 122 mln
Net loss 40 mln loss 111 mln loss 128 mln
EPS loss 5.47 yen loss 15.37 yen loss 17.25 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))